The levels of p-Bad (Ser112)/Bad and p-Bad (Ser136)/Bad were increased after MG, tended to decrease in the cells pretreated with PrRP31, and were significantly decreased by 46% and 52%, respectively, in the cells pretreated with palm11-PrRP31. The gene discussed is BAD; the disease is myasthenia gravis.